default author photo

Ao Zhang

Chinese Academy of Sciences (CAS) - Department of Medicinal Chemistry

Shanghai

China

  • Chinese Academy of Sciences (CAS) - Department of Medicinal Chemistry

SCHOLARLY PAPERS

2

DOWNLOADS

146

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Suppression of Asparagine Synthetase Enhances the Antitumor Potency of ART and Artemalogue SOMCL-14-221 in NSCLC Cells

Number of pages: 41 Posted: 23 Sep 2019
Ruoxuan Xiao Ruoxuan Xiao, Chunyong Ding, Hongwen Zhu, Xia Liu, Jing Gao, Qian Liu, Naixia Zhang, Ao Zhang and Hu Zhou
Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Receptor Research, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Receptor Research, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Receptor Research, Chinese Academy of Sciences (CAS) - Department of Analytical Chemistry, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Receptor Research, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Receptor Research, Chinese Academy of Sciences (CAS) - Department of Analytical Chemistry, Chinese Academy of Sciences (CAS) - Department of Medicinal Chemistry and Chinese Academy of Sciences (CAS) - Department of Analytical Chemistry
Downloads 105 (664,543)

Abstract:

Loading...

Artemisinin, NSCLC, ASNS, ER stress

2.

Glycogen Synthase Kinase 3β Inhibition Synergizes with PARP Inhibitors Through the Induction of Homologous Recombination Deficiency in Colorectal Cancer

Number of pages: 44 Posted: 27 Aug 2020
Ning Zhang, Yu-Nan Tian, Li-Na Zhou, Meng-Zhu Li, Shan-Shan Song, Xia-Juan Huan, Xu-Bing Bao, Ao Zhang, Ze-Hong Miao and Jin-Xue He
Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology, Chinese Academy of Sciences (CAS) - Department of Medicinal Chemistry, Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology and Chinese Academy of Sciences (CAS) - Division of Anti-Tumor Pharmacology
Downloads 41 (1,170,409)

Abstract:

Loading...

PARP inhibitor, GSK3β, homologous recombination repair, BRCA1, colorectal cancer